Sunday, May 19, 2024
HomePharma

Pharma

Pharma

Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%

Life Sciences Times - 0
Pharma

Novaliq Plans to File a Marketing Authorization Application for CyclASol® in the E.U. for the Treatment of Dry Eye Disease in July 2023

Life Sciences Times - 0
Pharma

Hims Launches Hard Mints – A Highly Personalized Treatment For Erectile Dysfunction

Life Sciences Times - 0
Pharma

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease

Life Sciences Times - 0
Pharma

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive...

Life Sciences Times - 0
Pharma

The Access to Advanced Health Institute Announces $9.9M Award to Develop a Nasal Spray Influenza RNA Vaccine Through Phase 1 Clinical Trials

Life Sciences Times - 0
Pharma

TEZSPIRE® approved for self-administration in the US with a new pre-filled pen

Life Sciences Times - 0
Pharma

Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia

Life Sciences Times - 0
Pharma

Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China

Life Sciences Times - 0
Pharma

Stemline Therapeutics, a Subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU™ (elacestrant) as the First and Only Treatment Specifically Indicated for Patients...

Life Sciences Times - 0
Pharma

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

Life Sciences Times - 0
Pharma

Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging

Life Sciences Times - 0
1...789...56Page 8 of 56

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv